Topics

Medulloblastoma | Outcomes | Risk-adapted therapy

Home > Publications > Topics > Medulloblastoma > Outcomes > Risk-adapted therapy

Liu H, Su Y, Zhang J, Chen X, Deng K, Chen L, Feng J, Wu X, Daniels C, Li Y, Zhang J, Zhao Y, Shi Y, Liu F, Feng Z, Wang D, Han D, Wang W, Wang M, Zhang J, Qi X, Li J, Gong J, Liu W, Tian Y, Chen R, Jiang T, Taylor MD, Li C, Tian Y, Qiu X.
Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapy.
Med. 2026 Mar 27;7(5):101076. doi: 10.1016/j.medj.2026.101076. PMID: 41903543˰ ˍ